The L2L brand, founded in 2014 (United States), from 65 sister brands and 2279 competing brands. L2L is owned by Zimmer Biomet, listed on the stock exchange of New York The sector of L2L is Medical Devices & Instruments.
Share price and profitability of the share Zimmer Biomet (L2L)
Buy Zimmer Biomet share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Zimmer Biomet
(L2L)
over 5 years*
USD 120.27
Stock market history Zimmer Biomet (L2L)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
